Top 5 Health Care Stocks That May Dip
The most overbought stocks in the health care sector presents an opportunity to go short on these overvalued companies.
SVB Leerink Maintains Outperform on AN2 Therapeutics, Lowers Price Target to $25
SVB Leerink analyst Joseph Schwartz maintains AN2 Therapeutics (NASDAQ:ANTX) with a Outperform and lowers the price target from $27 to $25.
AN2 Therapeutics Q3 EPS $(0.59) Up From $(3.35) YoY
AN2 Therapeutics (NASDAQ:ANTX) reported quarterly losses of $(0.59) per share. This is a 82.39 percent increase over losses of $(3.35) per share from the same period last year.
Uber, Lyft, AZZ And Other Big Losers From Tuesday
U.S. stocks closed mixed with the Nasdaq Composite dropping more than 100 points on Tuesday. Here is the list of some big stocks recording losses in the previous session.
Why Laser Photonics Shares Jumped By Around 44%; Here Are 72 Biggest Movers From Yesterday
Gainers
FedNat Holding Company (NASDAQ: FNHC) shares climbed 107.7% to close at $0.3395 on Tuesday.
AN2 Therapeutics Provides Update On Epetraborole Ex-U.S. Development Plan In Treatment-Refractory MAC Lung Disease
Epetraborole Data from Recently Completed Phase 1 Study in Japanese Subjects Supports Use of Once Daily, 500 mg Dose in Japanese Patients
Treatment-Refractory MAC Lung Disease Clinical Development Strategy to
Why Allena Pharmaceuticals Tumbled Over 30%; Here Are 85 Biggest Movers From Yesterday
Gainers
Shuttle Pharmaceuticals Holdings, Inc. (NASDAQ: SHPH) shares jumped 91.3% to close at $28.50 on Tuesday amid post-IPO volatility.